UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000015529
Receipt number R000018040
Scientific Title A multicenter randomized Phase III trial of enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer
Date of disclosure of the study information 2014/11/01
Last modified on 2022/11/01 11:42:09

No. Disposal Last modified on Item of update
1 Insert 2014/10/26 14:33:59
2 Update 2015/04/28 16:22:29 Key inclusion criteria
Key inclusion criteria
3 Update 2020/10/30 09:05:11 Acronym
Scientific Title:Acronym
4 Update 2021/11/17 16:23:22 Recruitment status
Date of IRB
Last follow-up date
5 Update 2022/11/01 11:38:38 Recruitment status
6 Update 2022/11/01 11:38:56 Publication of results
Number of participants that the trial has enrolled
7 Update 2022/11/01 11:41:19 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary person or sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
8 Update 2022/11/01 11:42:09 Randomization unit